EP3474792 - COMPOSITION AND APPARATUS FOR TREATMENT OF CHEMOTHERAPY INDUCED ALOPECIA [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 20.05.2020 Database last updated on 30.10.2024 | |
Former | Request for examination was made Status updated on 29.03.2019 | ||
Former | The international publication has been made Status updated on 29.12.2017 | ||
Former | unknown Status updated on 19.07.2017 | Most recent event Tooltip | 22.05.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Paxman Coolers Limited International House Penistone Road Fenay Bridge Huddersfield HD8 0LE / GB | [2019/18] | Inventor(s) | 01 /
GEORGOPOULOS, Nikolaos c/o University of Huddersfield Queensgate Huddersfield Yorkshire HD1 3DH / GB | 02 /
COLLETT, Andrew c/o University of Huddersfield Queensgate Huddersfield Yorkshire HD1 3DH / GB | 03 /
PAXMAN, Richard c/o Paxman Coolers Ltd International House Penistone Road Fenay Bridge Huddersfield Yorkshire HD1 3DH / GB | 04 /
AL-TAMEEMI, Wafaa, Dr. Huddersfield HD4 6NR / GB | [2022/13] |
Former [2019/18] | 01 /
GEORGOPOULOS, Nikolaos c/o University of Huddersfield Queensgate Huddersfield Yorkshire HD1 3DH / GB | ||
02 /
COLLETT, Andrew c/o University of Huddersfield Queensgate Huddersfield Yorkshire HD1 3DH / GB | |||
03 /
PAXMAN, Richard c/o Paxman Coolers Ltd International House Penistone Road Fenay Bridge Huddersfield Yorkshire HD1 3DH / GB | Representative(s) | Stephenson, Philip Bailey Walsh & Co LLP 1 York Place Leeds, LS1 2DR / GB | [2019/18] | Application number, filing date | 17737348.7 | 20.06.2017 | [2019/18] | WO2017GB51804 | Priority number, date | GB20160010910 | 22.06.2016 Original published format: GB 201610910 | [2019/18] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017220998 | Date: | 28.12.2017 | Language: | EN | [2017/52] | Type: | A1 Application with search report | No.: | EP3474792 | Date: | 01.05.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.12.2017 takes the place of the publication of the European patent application. | [2019/18] | Search report(s) | International search report - published on: | EP | 28.12.2017 | Classification | IPC: | A61F7/10, A61K31/198, A61K31/352 | [2019/18] | CPC: |
A61K31/352 (EP,US);
A61F7/10 (EP,US);
A61K31/198 (EP,US);
A61K31/375 (EP,US);
A61K9/0014 (US);
A61P17/14 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/18] | Title | German: | ZUSAMMENSETZUNG UND VORRICHTUNG ZUR BEHANDLUNG VON CHEMOTHERAPIEINDUZIERTER ALOPEZIE | [2019/18] | English: | COMPOSITION AND APPARATUS FOR TREATMENT OF CHEMOTHERAPY INDUCED ALOPECIA | [2019/18] | French: | TRAITEMENT DE L'ALOPÉCIE SECONDAIRE À LA CHIMIOTHÉRAPIE. | [2019/18] | Entry into regional phase | 22.01.2019 | National basic fee paid | 22.01.2019 | Designation fee(s) paid | 22.01.2019 | Examination fee paid | Examination procedure | 22.01.2019 | Amendment by applicant (claims and/or description) | 22.01.2019 | Examination requested [2019/18] | 22.01.2019 | Date on which the examining division has become responsible | 27.05.2020 | Despatch of a communication from the examining division (Time limit: M04) | 27.10.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 06.01.2021 | Reply to a communication from the examining division | 18.01.2023 | Despatch of a communication from the examining division (Time limit: M06) | 28.07.2023 | Reply to a communication from the examining division | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 06.01.2021 | Request for further processing filed | 06.01.2021 | Full payment received (date of receipt of payment) Request granted | 19.01.2021 | Decision despatched | Fees paid | Renewal fee | 08.05.2019 | Renewal fee patent year 03 | 16.06.2020 | Renewal fee patent year 04 | 25.05.2021 | Renewal fee patent year 05 | 16.06.2022 | Renewal fee patent year 06 | 26.04.2023 | Renewal fee patent year 07 | 22.05.2024 | Renewal fee patent year 08 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO9114424 (YUNIS ADEL A [US], et al); | [XY]WO9534303 (ARCTURUS PHARM CORP [US]); | [X]WO0230430 (ABBOTT LAB [US]); | [A]WO03047479 (PAXMAN COOLERS LTD [GB], et al); | [X]GB2477534 (LALVANI AJIT [GB], et al); | [Y]US2014046410 (WYATT DAVID [US]); |